Detail
LncRNA Name | HNF1A-AS1 |
Synonyms | HNF1A-AS1, C12orf27, NCRNA00262, FLJ38690, HAS1 |
Region | GRCh38_12:120941728-120980965 Sequence |
Ensembl | ENSG00000241388 |
RefSeq | NR_024345 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✔ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 M8170/3 |
Methods | Microarray, RT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP |
Sample | human HCC cell lines (Huh-7, MHCC-97 L, MHCC-97H, MHCC-LM3, SMMC-7721 and YY-8103 ), |
Expression Pattern | down-regulated |
Function Description | HNF1a activated the transcription of HNF1A-AS1 by directly binding to its promoter region. HNF1A-AS1 inhibited the growth and the metastasis of HCC cells in vitro and in vivo. Moreover, knockdown of HNF1A-AS1 reversed the suppressive effects of HNF1a on the migration and invasion of HCC cells. Importantly, HNF1A-AS1 directly bound to the C-terminal of SHP-1 with a high binding affinity (KD=59.57±14.29nM) and increased the phosphatase activity of SHP-1. Inhibition of SHP-1 enzymatic activity substantially reversed the HNF1a- or HNF1A-AS1-induced reduction on the metastatic property of HCC cells. |
Pubmed ID | 29466992 |
Year | 2018 |
Title | The HNF1a-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. |
External Links |
Links for HNF1A-AS1 | GenBank HGNC lncrnadb Noncode |
Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.